{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:43:00Z","timestamp":1769510580767,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41429-025-00878-9","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:35:12Z","timestamp":1762508112000},"page":"110-121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reversion of multidrug resistance in clinical isolates of Escherichia coli using non-steroidal anti-inflammatory drugs (NSAIDs)"],"prefix":"10.1038","volume":"79","author":[{"given":"Amina","family":"Hayat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aalia","family":"Khanem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikram","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6422-3842","authenticated-orcid":false,"given":"Farhan","family":"Younas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"878_CR1","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s42003-021-02854-z","volume":"4","author":"Y Liu","year":"2021","unstructured":"Liu Y, Tong Z, Shi J, Jia Y, Deng T, Wang Z. Reversion of antibiotic resistance in multidrug-resistant pathogens using non-antibiotic pharmaceutical benzydamine. Commun Biol. 2021;4:1328.","journal-title":"Commun Biol"},{"key":"878_CR2","doi-asserted-by":"publisher","first-page":"106380","DOI":"10.1016\/j.ijantimicag.2021.106380","volume":"58","author":"VS Foletto","year":"2021","unstructured":"Foletto VS, da Rosa TF, Serafin MB, Bottega A, H\u00f6rner R. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review. Int J Antimicrob Agents. 2021;58:106380.","journal-title":"Int J Antimicrob Agents"},{"key":"878_CR3","first-page":"90","volume":"4","author":"E Etebu","year":"2016","unstructured":"Etebu E, Arikekpar I. Antibiotics: classification and mechanisms of action with emphasis on molecular perspectives. Int J Appl Microbiol Biotechnol Res. 2016;4:90\u2013101.","journal-title":"Int J Appl Microbiol Biotechnol Res"},{"key":"878_CR4","doi-asserted-by":"publisher","first-page":"e1260","DOI":"10.1002\/mbo3.1260","volume":"11","author":"DV Patangia","year":"2022","unstructured":"Patangia DV, Anthony Ryan C, Dempsey E, Paul Ross R, Stanton C. Impact of antibiotics on the human microbiome and consequences for host health. Microbiologyopen. 2022;11:e1260.","journal-title":"Microbiologyopen"},{"key":"878_CR5","doi-asserted-by":"crossref","unstructured":"Nadgir CA, Biswas DA. Antibiotic resistance and its impact on disease management. Cureus. 2023;15:e38251.","DOI":"10.7759\/cureus.38251"},{"key":"878_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nature.2017.21550","volume":"543","author":"C Willyard","year":"2017","unstructured":"Willyard C. Drug-resistant bacteria ranked. Nature. 2017;543:15.","journal-title":"Nature"},{"key":"878_CR7","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/pathogens10101310","volume":"10","author":"G Mancuso","year":"2021","unstructured":"Mancuso G, Midiri A, Gerace E, Biondo C. Bacterial antibiotic resistance: the most critical pathogens. Pathogens. 2021;10:1310 s Note: MDPI stays neu-tral with regard to jurisdictional claims in \u2026, 2021.","journal-title":"Pathogens"},{"key":"878_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ijmm.2010.04.005","volume":"300","author":"Y Pfeifer","year":"2010","unstructured":"Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol. 2010;300:371\u20139.","journal-title":"Int J Med Microbiol"},{"key":"878_CR9","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1086\/319757","volume":"32","author":"E Lautenbach","year":"2001","unstructured":"Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001;32:1162\u201371.","journal-title":"Clin Infect Dis"},{"key":"878_CR10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cbi.2019.05.050","volume":"308","author":"M Ayaz","year":"2019","unstructured":"Ayaz M, Ullah F, Sadiq A, Ullah F, Ovais M, Ahmed J, et al. Synergistic interactions of phytochemicals with antimicrobial agents: potential strategy to counteract drug resistance. Chem-Biol Interact. 2019;308:294\u2013303.","journal-title":"Chem-Biol Interact"},{"key":"878_CR11","doi-asserted-by":"publisher","first-page":"116290","DOI":"10.1016\/j.watres.2020.116290","volume":"185","author":"H Wang","year":"2020","unstructured":"Wang H, Wang J, Li S, Ding G, Wang K, Zhuang T, et al. Synergistic effect of UV\/chlorine in bacterial inactivation, resistance gene removal, and gene conjugative transfer blocking. Water Res. 2020;185:116290.","journal-title":"Water Res"},{"key":"878_CR12","doi-asserted-by":"crossref","unstructured":"Abo-Shama UH, El-Gendy H, Mousa WS, Hamouda RA, Yousuf WE, Hetta HF et al. Synergistic and antagonistic effects of metal nanoparticles in combination with antibiotics against some reference strains of pathogenic microorganisms. Infection Drug Resistance 2020:351\u201362.","DOI":"10.2147\/IDR.S234425"},{"key":"878_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/1040841X.2019.1599813","volume":"45","author":"Y Liu","year":"2019","unstructured":"Liu Y, Li R, Xiao X, Wang Z. Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria. Crit Rev Microbiol. 2019;45:301\u201314.","journal-title":"Crit Rev Microbiol"},{"key":"878_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nchembio.559","volume":"7","author":"L Ejim","year":"2011","unstructured":"Ejim L, Farha MA, Falconer SB, Wildenhain J, Coombes BK, Tyers M, et al. Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat Chem Biol. 2011;7:348\u201350.","journal-title":"Nat Chem Biol"},{"key":"878_CR15","doi-asserted-by":"publisher","first-page":"103755","DOI":"10.1016\/j.micpath.2019.103755","volume":"137","author":"M Altaf","year":"2019","unstructured":"Altaf M, Ijaz M, Ghaffar A, Rehman A, Avais M. Antibiotic susceptibility profile and synergistic effect of non-steroidal anti-inflammatory drugs on antibacterial activity of resistant antibiotics (Oxytetracycline and Gentamicin) against methicillin resistant Staphylococcus aureus (MRSA). Micro Pathogenesis. 2019;137:103755.","journal-title":"Micro Pathogenesis"},{"key":"878_CR16","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.3390\/cells10123524","volume":"10","author":"A Sinniah","year":"2021","unstructured":"Sinniah A, Yazid S, Flower RJ. From NSAIDs to glucocorticoids and beyond. Cells. 2021;10:3524.","journal-title":"Cells"},{"key":"878_CR17","doi-asserted-by":"publisher","first-page":"113598","DOI":"10.1016\/j.fct.2022.113598","volume":"172","author":"NK Panchal","year":"2023","unstructured":"Panchal NK, Sabina EP. Non-steroidal anti-inflammatory drugs (NSAIDs): A current insight into its molecular mechanism eliciting organ toxicities. Food Chem Toxicol. 2023;172:113598.","journal-title":"Food Chem Toxicol"},{"key":"878_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/pharmaceutics15010004","volume":"15","author":"F Tabatabaeifar","year":"2022","unstructured":"Tabatabaeifar F, Isaei E, Kalantar-Neyestanaki D, Morones-Ram\u00edrez JR. Antimicrobial and antibiofilm effects of combinatorial treatment formulations of anti-inflammatory drugs\u2014common antibiotics against pathogenic bacteria. Pharmaceutics. 2022;15:4.","journal-title":"Pharmaceutics"},{"key":"878_CR19","doi-asserted-by":"publisher","unstructured":"Kalayci S. Antimicrobial properties of various non-antibiotic drugs against microorganisms. J Bioanal Biomed 8: e142. https:\/\/doi.org\/10.4172\/1948-593X. 1000e1 42 Volume 8\u2022 Issue 4\u2022 1000e142 J Bioanal Biomed ISSN: 1948-593X JBABM, an open access journal","DOI":"10.4172\/1948-593X"},{"key":"878_CR20","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/jac\/dkn046","volume":"61","author":"P Palit","year":"2008","unstructured":"Palit P, Ali N. Oral therapy with sertraline, a selective serotonin reuptak e inhibitor, shows activity against Leishmania donovani. J Antimicrob Chemother 2016. 2008;61:1120\u20134.","journal-title":"J Antimicrob Chemother 2016"},{"key":"878_CR21","doi-asserted-by":"publisher","first-page":"707629","DOI":"10.3389\/fmicb.2021.707629","volume":"12","author":"RC Paes Leme","year":"2021","unstructured":"Paes Leme RC, da Silva RB. Antimicrobial activity of non-steroidal anti-inflammatory drugs on biofilm: Current evidence and potential for drug repurposing. Front Microbiol. 2021;12:707629.","journal-title":"Front Microbiol"},{"key":"878_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1128\/AAC.48.1.41-47.2004","volume":"48","author":"MA Alem","year":"2004","unstructured":"Alem MA, Douglas LJ. Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrobial agents Chemother. 2004;48:41\u20137.","journal-title":"Antimicrobial agents Chemother"},{"key":"878_CR23","first-page":"673131","volume":"2012","author":"M Milani","year":"2012","unstructured":"Milani M, Iacobelli P. Vaginal use of Ibuprofen isobutanolammonium (ginenorm): efficacy, tolerability, and pharmacokinetic data: a review of available data. Int Sch Res Not. 2012;2012:673131.","journal-title":"Int Sch Res Not"},{"key":"878_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10787-009-0016-x","volume":"17","author":"K Rainsford","year":"2009","unstructured":"Rainsford K. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology. 2009;17:275\u2013342.","journal-title":"Inflammopharmacology"},{"key":"878_CR25","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.3390\/biomedicines11112936","volume":"11","author":"Q Chen","year":"2023","unstructured":"Chen Q, Ilanga M, Simbassa SB, Chirra B, Shah KN, Cannon CL. Synergistic antimicrobial effects of ibuprofen combined with standard-of-care antibiotics against cystic fibrosis pathogens. Biomedicines. 2023;11:2936.","journal-title":"Biomedicines"},{"key":"878_CR26","first-page":"fny251","volume":"365","author":"T Verma","year":"2018","unstructured":"Verma T, Bhaskarla C, Sadhir I, Sreedharan S, Nandi D. Non-steroidal anti-inflammatory drugs, acetaminophen and ibuprofen, induce phenotypic antibiotic resistance in Escherichia coli: roles of marA and acrB. FEMS Microbiol Lett. 2018;365:fny251.","journal-title":"FEMS Microbiol Lett"},{"key":"878_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11274-022-03316-2","volume":"38","author":"S Khodaparast","year":"2022","unstructured":"Khodaparast S, Ghanbari F, Zamani H. Evaluation of the effect of ibuprofen in combination with ciprofloxacin on the virulence-associated traits, and efflux pump genes of Pseudomonas aeruginosa. World J Microbiol Biotechnol. 2022;38:125.","journal-title":"World J Microbiol Biotechnol"},{"key":"878_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/antibiotics9090591","volume":"9","author":"C Le\u00e3o","year":"2020","unstructured":"Le\u00e3o C, Borges A, Sim\u00f5es M. NSAIDs as a drug repurposing strategy for biofilm control. Antibiotics. 2020;9:591.","journal-title":"Antibiotics"},{"key":"878_CR29","doi-asserted-by":"publisher","first-page":"105697","DOI":"10.1016\/j.micpath.2022.105697","volume":"170","author":"MR Xavier","year":"2022","unstructured":"Xavier MR, Freitas TS, Pereira RL, Marinho EM, Bandeira PN, de Sousa AP, et al. Anti-inflammatory effect, antibiotic potentiating activity against multidrug-resistant strains of Escherichia coli and Staphylococcus aureus, and evaluation of antibiotic resistance mechanisms by the ibuprofen derivative methyl 2-(-4-isobutylphenyl) propanoate. Micro Pathogenesis. 2022;170:105697.","journal-title":"Micro Pathogenesis"},{"key":"878_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.tibtech.2012.12.006","volume":"31","author":"RJ Worthington","year":"2013","unstructured":"Worthington RJ, Melander C. Combination approaches to combat multidrug-resistant bacteria. Trends Biotechnol. 2013;31:177\u201384.","journal-title":"Trends Biotechnol"},{"key":"878_CR31","doi-asserted-by":"publisher","unstructured":"Zimmermann P, Curtis N. Antimicrobial effects of antipyretics. Antimicrobial Agents and Chemotherapy. 2017;61:e02268-16 https:\/\/doi.org\/10.1128\/aac.02268-02216.","DOI":"10.1128\/aac.02268-02216"},{"key":"878_CR32","doi-asserted-by":"crossref","unstructured":"Belay D, Kenubih A, Yesuf M, Kebede E, Yayeh M, Birhan M Antioxidant and antimicrobial activity of solvent fractions of Calpurnia aurea (Ait.) Benth.(Fabaceae). J Exp Pharmacol. 2021;13:499\u2013509.","DOI":"10.2147\/JEP.S285872"},{"key":"878_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.mimet.2019.05.003","volume":"162","author":"A Veiga","year":"2019","unstructured":"Veiga A, Maria da Gra\u00e7a TT, Rossa LS, Mengarda M, Stofella NC, Oliveira LJ, et al. Colorimetric microdilution assay: Validation of a standard method for determination of MIC, IC50%, and IC90% of antimicrobial compounds. J Microbiol Methods. 2019;162:50\u201361.","journal-title":"J Microbiol Methods"},{"key":"878_CR34","doi-asserted-by":"publisher","first-page":"116096","DOI":"10.1016\/j.diagmicrobio.2023.116096","volume":"108","author":"MQ de Souza","year":"2024","unstructured":"de Souza MQ, Bierhals DV, Reis AJ, Chimara E, Vianna JS, von Groll A, et al. 2, 3, 5-triphenyl tetrazolium chloride as colorimetric indicator for drug susceptibility testing against nontuberculous mycobacteria. Diagn Microbiol Infect Dis. 2024;108:116096.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"878_CR35","first-page":"49","volume":"10","author":"DD Lee","year":"2007","unstructured":"Lee DD, Lee EY, Jeong SH, Chang CL. Evaluation of a colorimetric broth microdilution method for antimicrobial susceptibility testing using 2, 3, 5-triphenyltetrazolium chloride. Korean J Clin Microbiol. 2007;10:49\u201353.","journal-title":"Korean J Clin Microbiol"},{"key":"878_CR36","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.5897\/AJMR2016.8179","volume":"10","author":"EF Ahmed","year":"2016","unstructured":"Ahmed EF, Abd El-Baky RM, Ahmed ABF, Fawzy NG, Aziz NA, Gad GFM. Evaluation of antibacterial activity of some non-steroidal anti-inflammatory drugs against Escherichia coli causing urinary tract infection. Afr J Microbiol Res. 2016;10:1408\u201316.","journal-title":"Afr J Microbiol Res"},{"key":"878_CR37","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.foodcont.2016.10.048","volume":"73","author":"C Xu","year":"2017","unstructured":"Xu C, Li J, Yang L, Shi F, Yang L, Ye M. Antibacterial activity and a membrane damage mechanism of Lachnum YM30 melanin against Vibrio parahaemolyticus and Staphylococcus aureus. Food Control. 2017;73:1445\u201351.","journal-title":"Food Control"},{"key":"878_CR38","doi-asserted-by":"publisher","first-page":"869953","DOI":"10.3389\/fmicb.2022.869953","volume":"13","author":"W Zhong","year":"2022","unstructured":"Zhong W, Chen K, Yang L, Tang T, Jiang S, Guo J, et al. Essential oils from Citrus unshiu Marc. effectively kill Aeromonas hydrophila by destroying cell membrane integrity, influencing cell potential, and leaking intracellular substances. Front Microbiol. 2022;13:869953.","journal-title":"Front Microbiol"},{"key":"878_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4248\/IJOS11022","volume":"3","author":"L Chen","year":"2011","unstructured":"Chen L, Wen. Ym. The role of bacterial biofilm in persistent infections and control strategies. Int J oral Sci. 2011;3:66\u201373.","journal-title":"Int J oral Sci"},{"key":"878_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jgar.2017.03.012","volume":"10","author":"EWL Chan","year":"2017","unstructured":"Chan EWL, Yee ZY, Raja I, Yap JKY. Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus. J Glob Antimicrob Resist. 2017;10:70\u20134.","journal-title":"J Glob Antimicrob Resist"},{"key":"878_CR41","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/ja.2007.45","volume":"60","author":"Y Cai","year":"2007","unstructured":"Cai Y, Wang R, Pei F, Liang B-B. Antibacterial activity of allicin alone and in combination with \u03b2-lactams against Staphylococcus spp. and Pseudomonas aeruginosa. J Antibiotics. 2007;60:335\u20138.","journal-title":"J Antibiotics"},{"key":"878_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-14-47","volume":"14","author":"C-H Lee","year":"2014","unstructured":"Lee C-H, Su L-H, Liu J-W, Chang C-C, Chen R-F, Yang K-D. Aspirin enhances opsonophagocytosis and is associated to a lower risk for Klebsiella pneumoniae invasive syndrome. BMC Infect Dis. 2014;14:1\u20137.","journal-title":"BMC Infect Dis"},{"key":"878_CR43","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1128\/AAC.00735-10","volume":"55","author":"AM Kalle","year":"2011","unstructured":"Kalle AM, Rizvi A. Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor. Antimicrob Agents Chemother. 2011;55:439\u201342.","journal-title":"Antimicrob Agents Chemother"},{"key":"878_CR44","first-page":"66","volume":"5","author":"EF Ahmed","year":"2017","unstructured":"Ahmed EF, El-Baky R, Ahmed ABF, Waly NG, Gad GFM. Antibacterial activity of some non-steroidal anti-inflammatory drugs against bacteria causing urinary tract infection. Am J Infect Dis Microbiol. 2017;5:66\u201373.","journal-title":"Am J Infect Dis Microbiol"},{"key":"878_CR45","first-page":"108","volume":"23","author":"T Akhter","year":"2010","unstructured":"Akhter T, Baqai R, Aziz M. Antibacterial effect of NSAIDS on clinical isolates of urinary tract infection and diabetic foot infection. Pak J Pharm Sci. 2010;23:108\u201313.","journal-title":"Pak J Pharm Sci"},{"key":"878_CR46","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3906\/sag-2003-60","volume":"51","author":"I \u00d6zt\u00fcrk","year":"2021","unstructured":"\u00d6zt\u00fcrk I, Erac Y, Kirmizibayrak PB, Ermertcan \u015e. Nonsteroidal antiinflammatory drugs alter antibiotic susceptibility and expression ofvirulence-related genes and protein A of Staphylococcus aureus. Turk J Med Sci. 2021;51:835\u201347.","journal-title":"Turk J Med Sci"},{"key":"878_CR47","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00284-024-03632-w","volume":"81","author":"T Verma","year":"2024","unstructured":"Verma T, Nandini SS, Singh V, Raghavan A, Annappa H, Bhaskarla C, et al. Divergent roles of Escherichia coli encoded lon protease in imparting resistance to uncouplers of oxidative phosphorylation: roles of marA, rob, soxS and acrB. Curr Microbiol. 2024;81:98.","journal-title":"Curr Microbiol"},{"key":"878_CR48","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jhin.2010.05.011","volume":"76","author":"P Naves","year":"2010","unstructured":"Naves P, Del Prado G, Huelves L, Rodriguez-Cerrato V, Ruiz V, Ponte M, et al. Effects of human serum albumin, ibuprofen and N-acetyl-L-cysteine against biofilm formation by pathogenic Escherichia coli strains. J Hosp Infect. 2010;76:165\u201370.","journal-title":"J Hosp Infect"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00878-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00878-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00878-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T23:02:48Z","timestamp":1769468568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00878-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["878"],"URL":"https:\/\/doi.org\/10.1038\/s41429-025-00878-9","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}